Evaluation of desmoglein 1 and desmoglein 3 autoantibodies in oral cancer: A pilot study

Evaluation of desmoglein 1 and desmoglein 3 autoantibodies in oral cancer: A pilot study

Background: Carcinogenesis is a complex multistep process involving alterations at the cellular level. Alteration in cell-to-cell adhesion of oral epithelium plays an important role in carcinogenesis and metastasis. The alterations in the role of desmosomal components due to autoantibodies to desmog...

Full description

Bibliographic Details
Main Authors:	Pavan Kumar Yellarthi, Arvind Muthukrishnan, Raghurama Rao Gandikota, Y Sandhya Pavankumar, Divya Uppala
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Journal of Indian Academy of Oral Medicine and Radiology
Subjects:	autoantibodies desmoglein 3 desmoglein 1 direct immunofluorescence elisa oral squamous cell carcinoma
Online Access:	http://www.jiaomr.in/article.asp?issn=0972-1363;year=2023;volume=35;issue=4;spage=473;epage=477;aulast=Yellarthi

Similar Items

Squamous cell carcinoma of the soft palate associated with autoantibodies to desmoglein 1 and 3
by: Yoshifumi Maumi, et al.
Published: (2013-10-01)

Desmoglein compensation hypothesis fidelity assessment in Pemphigus
by: Lauren Sielski, et al.
Published: (2022-09-01)

Detection of anti-desmoglein antibodies in oral lichen planus: What do we know so far
by: Dario Didona, et al.
Published: (2022-10-01)

Factors associated with non-pathogenic antibodies against desmoglein-3 in pemphigus foliaceus
by: Sebastian Vernal, et al.
Published: (2024-09-01)

IgG reactivity to different desmoglein-3 ectodomains in pemphigus vulgaris: novel panels for assessing disease severity
by: Soheil Tavakolpour, et al.
Published: (2024-10-01)

A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
by: Roberta Lotti, et al.
Published: (2023-05-01)

Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris
by: Giulia Di Lullo, et al.
Published: (2019-06-01)

Comparative Transcriptome Analysis Identifies Desmoglein-3 as a Potential Oncogene in Oral Cancer Cells
by: Hong Wan, et al.
Published: (2023-11-01)

Hereditary epidermolytic palmoplantar keratosis due to a novel desmoglein‐1 mutation: A case report
by: Kevin Koschitzki, et al.
Published: (2024-05-01)

Pemphigus Foliaceus Autoantibodies Induce Redistribution Primarily of Extradesmosomal Desmoglein 1 in the Cell Membrane
by: Matthias Hiermaier, et al.
Published: (2022-05-01)

Alteration of reactive oxygen species master transcription factor Nrf2 in keratinocytes exposed to monoclonal pathogenic antibody AK23 against desmoglein-3 in pemphigus vulgaris
by: Faris Mohsin Ali Alabeedi
Published: (2024-12-01)

Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation
by: Zhimin Xie, et al.
Published: (2023-11-01)

The prognostic and clinicopathological significance of desmoglein 2 in human cancers: a systematic review and meta-analysis
by: Jiantao Wang, et al.
Published: (2022-03-01)

Desmoglein-2 as a cancer modulator: friend or foe?
by: Kay K. Myo Min, et al.
Published: (2023-12-01)

Desmoglein‐3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells
by: Usama Sharif Ahmad, et al.
Published: (2022-04-01)

Determining the potential of desmoglein 3 as a sensitive and specific immunohistochemical marker for the detection of micrometastasis in patients with primary oral squamous cell carcinoma
by: Shruti Nagvekar, et al.
Published: (2016-12-01)

Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus
by: Maryam Mobarakabadi, et al.
Published: (2019-12-01)

Estradiol-mediated enhancement of the human ectocervical epithelial barrier correlates with desmoglein-1 expression in the follicular menstrual phase
by: Frideborg Bradley, et al.
Published: (2024-10-01)

HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies
by: Ines Lakoš Jukić, et al.
Published: (2023-07-01)

IgG/IgA pemphigus with differing regional presentations
by: Hok Fai Cheng, MBBS(HK), MRCP(UK), FHKAM(Medicine), et al.
Published: (2022-10-01)

Whole-exome sequencing identified a novel desmoglein-2 gene mutation associated with familial arrhythmogenic right ventricular cardiomyopathy
by: Nianwei Zhou, et al.
Published: (2017-01-01)

The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the “Super Compensation Hypothesis”
by: Animesh A. Sinha, et al.
Published: (2018-08-01)

Unusual direct immunofluorescence (DIF) pattern in pemphigus herpetiformis- A case report
by: Rawat Kavita, et al.
Published: (2023-01-01)

Ultrastructural skin alterations of healthy subjects with anti-desmoglein 1 antibodies in endemic areas to pemphigus foliaceus: A case series
by: Willy Ramos, et al.
Published: (2023-12-01)

Keratinocyte Binding Assay Identifies Anti-Desmosomal Pemphigus Antibodies Where Other Tests Are Negative
by: Federica Giurdanella, et al.
Published: (2018-04-01)

Quality-controlled characterization of a monoclonal antibody specific to an EC5-domain of human desmoglein 3 for pemphigus research
by: Rüdiger Eming, et al.
Published: (2024-10-01)

Autoimmune pemphigus: difficulties in diagnosis and the molecular mechanisms underlying the disease
by: Olga Simionescu, et al.
Published: (2025-03-01)

Binding Mechanism Elucidation of the Acute Respiratory Disease Causing Agent Adenovirus of Serotype 7 to Desmoglein-2
by: Marc-André Hograindleur, et al.
Published: (2020-09-01)

Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
by: Ambreen Rehman, et al.
Published: (2021-06-01)

Mouse models of pemphigus: valuable tools to investigate pathomechanisms and novel therapeutic interventions
by: Shirin Emtenani, et al.
Published: (2023-04-01)

Inhibitory effect of apigenin on AK23-induced desmoglein3 depletion in HaCaT cell model of pemphigus vulgaris via suppression of p38 MAPK phosphorylation
by: Ji-Eun Lee, et al.
Published: (2024-11-01)

Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer
by: Ji-Yuan Han, et al.
Published: (2024-04-01)

Comparison of BIOCHIP Mosaic Based Indirect Immunofluorescence and Oral Direct Immunofluorescence in Patients with Oral Mucosal Pemphigus
by: Amrithaa Muralitharan, et al.
Published: (2024-10-01)

Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity
by: Kristina Seiffert-Sinha, et al.
Published: (2018-04-01)

Comments on Stone et al, “A case of secondary syphilis presenting like pemphigus with positive direct immunofluorescence”
by: Camila Cordero Pacheco, MD, et al.
Published: (2024-10-01)

Endurance Training Provokes Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Heterozygous Desmoglein-2 Mutants: Alleviation by Preload Reduction
by: Larissa Fabritz, et al.
Published: (2024-04-01)

Paraneoplastic pemphigus
by: Sang Eun Lee, et al.
Published: (2010-03-01)

Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
by: Yanxia Bi, et al.
Published: (2022-08-01)

From Insect Bites to a Skin Autoimmune Disease: A Conceivable Pathway to Endemic Pemphigus Foliaceus
by: Ning Li, et al.
Published: (2022-05-01)

Paraneoplastic Pemphigus Autoantibodies Against C-terminus of Desmoplakin Induced Acantholysis In Vitro and In Vivo
by: Xue Wang, et al.
Published: (2022-07-01)